Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation

scientific article published on 19 May 2014

Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TID.12232
P8608Fatcat IDrelease_kv5v7rhqj5cb5aq2nen3mvoc64
P698PubMed publication ID24834833

P50authorJoan GavaldàQ40625420
Oscar LenQ42234079
Núria SabéQ42253913
Elisa CorderoQ43130677
Pilar Martín-DávilaQ52287220
Carlos CerveraQ57951489
P2093author name stringA Ramos
J Torre-Cisneros
M Montejo
A Pahissa
J R Azanza
M C Fariñas
DAPTOSOT (Daptomycin in Solid Organ Transplantation) Study Group
P2860cites workThe safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infectionsQ34330270
Vancomycin: a 50-year reassessmentQ34472258
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusQ34558111
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ34783668
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjectsQ34882125
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteriaQ35759049
The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureusQ36779557
Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsQ37124177
Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patientsQ37532488
Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson diseaseQ41858729
Vancomycin-resistant Enterococcus infections in solid organ transplantationQ42272348
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patientsQ43069045
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditisQ43443557
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapyQ44959085
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.Q45982608
An HPLC assay for daptomycin in serumQ46340635
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ46826194
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.Q54174345
Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.Q54500493
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectgram-positive bacteriaQ857288
organ transplantationQ69253852
P304page(s)532-538
P577publication date2014-05-19
P1433published inTransplant Infectious DiseaseQ15749562
P1476titleDaptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation
P478volume16

Reverse relations

cites work (P2860)
Q57815117Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
Q38845084Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.
Q41771325Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms
Q38757179Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia.

Search more.